Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1000 of 3284 entries
View as:

A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)

Phase: N/A Priority: Normal
NCT ID: NCT04590235 Org: User:
Start: 12/16/20 End: 08/31/26 Due: 08/31/27

Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03402841 Org: User:
Start: 01/30/18 End: 03/10/22 Due: 03/10/23

Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02482311 Org: User:
Start: 07/01/15 End: 08/22/19 Due: 08/22/20

Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00399035 Org: User:
Start: 11/30/06 End: 08/31/16 Due: 08/31/17

An Open-Label Phase 1 Study of Ceralasertib in Japanese Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05469919 Org: User:
Start: 06/09/22 End: 03/12/24 Due: 03/12/25

Patient Reported Outcomes in Adults With Severe Eosinophilic Asthma on Benralizumab.

Phase: N/A Priority: Normal
NCT ID: NCT03833141 Org: User:
Start: 11/12/18 End: 05/28/24 Due: 05/28/25

A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT05246514 Org: User:
Start: 07/13/22 End: 11/04/24 Due: 11/04/25

To Assess the Safety, Tolerability and Pharmacokinetics of AZD2820 After Single Ascending Doses

Phase: N/A Priority: Normal
NCT ID: NCT01332214 Org: User:
Start: 05/31/11 End: 11/30/11 Due: 11/30/12

Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides

Phase: N/A Priority: Normal
NCT ID: NCT00812955 Org: User:
Start: 11/30/08 End: 06/30/09 Due: 06/30/10

ATAC - Pharmacokinetics (PK) Sub-Protocol

Phase: N/A Priority: Normal
NCT ID: NCT00784862 Org: User:
Start: 06/30/98 End: 03/31/99 Due: 03/31/00

Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of AZD8566.

Phase: N/A Priority: Normal
NCT ID: NCT00844103 Org: User:
Start: 01/31/09 End: 04/30/09 Due: 04/30/10

A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03235050 Org: User:
Start: 08/02/17 End: 06/14/19 Due: 06/14/20

Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT05952024 Org: User:
Start: 07/16/24 End: 08/24/27 Due: 08/24/28

A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China

Phase: N/A Priority: Normal
NCT ID: NCT06422663 Org: User:
Start: 03/22/24 End: 03/13/25 Due: 03/13/26

A 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT06015737 Org: User:
Start: 06/29/24 End: 12/29/27 Due: 12/29/28

The Use of a Forecasting System for Predicting Exacerbations of COPD

Phase: N/A Priority: Normal
NCT ID: NCT00788645 Org: User:
Start: 08/31/08 End: 03/31/09 Due: 03/31/10

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin

Phase: N/A Priority: Normal
NCT ID: NCT01225562 Org: User:
Start: 10/31/10 End: 12/31/14 Due: 12/31/15

Exacerbations Among Patients Receiving Breztri (EROS Study)

Phase: N/A Priority: Normal
NCT ID: NCT06514144 Org: User:
Start: 10/01/22 End: 03/07/23 Due: 03/07/24

A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186

Phase: N/A Priority: Normal
NCT ID: NCT05694741 Org: User:
Start: 12/20/22 End: 05/10/23 Due: 05/10/24

LIFE NIS, GERD-Patients - Evaluation of Burden of Disease Determined by GERD Impact Scale (GIS)

Phase: N/A Priority: Normal
NCT ID: NCT00567619 Org: User:
Start: 07/31/07 End: - Due: -

Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain

Phase: N/A Priority: Normal
NCT ID: NCT01384292 Org: User:
Start: 06/30/11 End: 09/30/12 Due: 09/30/13

A Placebo-controlled Four Way Crossover Study to Asses the Effect of a Single Oral Dose of NKTR-118 on QTc Interval in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01325415 Org: User:
Start: 04/30/11 End: 07/31/11 Due: 07/31/12

Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Phase: N/A Priority: Normal
NCT ID: NCT00119626 Org: User:
Start: 06/30/03 End: 02/28/05 Due: 02/28/06

Multiple Ascending Dose Study for AZD 7268 in Japanese Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01116011 Org: User:
Start: 04/30/10 End: 07/31/10 Due: 07/31/11

Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1386

Phase: N/A Priority: Normal
NCT ID: NCT00690079 Org: User:
Start: 02/29/08 End: 10/31/08 Due: 10/31/09